Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the filing of a provisional patent application covering a wearable transdermal delivery platform that uses a pulsed magnetic field to ...
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH), a clinical-stage biotechnology company developing an innovative ...
Provisional patent applications are popular in the U.S. for the various advantages they may provide applicants, including lower filing costs, less restrictive United States Patent and Trademark Office ...
Leveraging its PharmaPatch™ experience, the Company is introducing PatchPrint™ to support existing microneedle patch programs and expand into on-demand personalized patch solutions, including peptide ...
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory ...
Detailed price information for Visionwave Holdings Inc (VWAV-Q) from The Globe and Mail including charting and trades.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. You have a great idea for an invention, and you think it is ...
For startups sensitive to cash burn rate, provisional patent applications often seem like the perfect solution—lower filing fees, simplified requirements, and a full year to file the "real" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results